Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome
- 2 January 2016
- journal article
- research article
- Published by Taylor & Francis Ltd in Avian Pathology
- Vol. 45 (1), 26-37
- https://doi.org/10.1080/03079457.2015.1110850
Abstract
We tested the level of protection provided by the Rispens CVI988 (Rispens) vaccine against challenge with a virulent Marek's disease virus (MDV) pathotype (vMDV) and a very virulent pathotype (vvMDV) and the accuracy of a range of predictive measures of Marek's disease (MD) incidence and vaccine take. Commercial layer chicks (n = 236) were vaccinated (or not) with 4000 plaque-forming units (pfu) of Rispens vaccine at hatch and challenged (or not) with 500 pfu of each challenge virus five days post vaccination. The vvMDV pathotype FT158 induced higher MD incidence (65%) and mortality (33%) when compared with the vMDV pathotype MPF57 (39% and 8%, respectively). The protective index provided by the Rispens vaccine against FT158 (61%) did not differ significantly from that against MPF57 (66%). This provides additional evidence that protection provided by the Rispens vaccine is not influenced by pathotype determined in studies using vaccines of other Mardivirus species. The challenge viruses did not differ in MDV or Rispens viral load in spleen at 14 dpc (days post challenge) determined by specific quantitative polymerase chain reaction test. MDV load in peripheral blood leucocytes at 7 and 14 dpc, splenocytes at 14 dpc, feather cells at 14 and 21 dpc and isolator dust at 21 dpc were significant early indicators of subsequent MD incidence to 56 dpc. These are potentially useful as the sampling can be carried out well before the onset of MD and some measures are non-invasive. The Rispens viral load in both invasive and non-invasive samples was more useful as a measure of vaccine take.Keywords
Funding Information
- Australian Egg Corporation Limited (1UN111)
- University of New England (Internal student grant)
This publication has 42 references indexed in Scilit:
- Correlation Between Marek's Disease Virus Pathotype and ReplicationAvian Diseases, 2014
- Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickensVaccine, 2014
- VACCINATION AND REDUCED COHORT DURATION CAN DRIVE VIRULENCE EVOLUTION: MAREK’S DISEASE VIRUS AND INDUSTRIALIZED AGRICULTUREEvolution, 2012
- Differential quantification of cloned CVI988 vaccine strain and virulent RB-1B strain of Marek’s disease viruses in chicken tissues, using real-time PCRResearch in Veterinary Science, 2011
- Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge modelAvian Pathology, 2007
- Use of Marek’s disease vaccines: could they be driving the virus to increasing virulence?Expert Review of Vaccines, 2005
- Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine virusesAvian Pathology, 2004
- Vaccination against Marek's diseasePublished by Elsevier BV ,2004
- Genetic Resistance to Marek’s DiseaseCurrent Topics in Microbiology and Immunology, 2001
- Effect of maternal antibody on Marek's diseaseVeterinary Record, 1969